Ligand Pharmaceuticals Incorporated (LGND)

NASDAQ: LGND · Real-Time Price · USD

104.48

+1.97 (1.92%)

At close: May 9, 2025, 4:00 PM

104.48

0.00 (0.00%)

After-hours: May 9, 2025, 4:05 PM EDT

Ligand Pharmaceuticals Market Cap

Ligand Pharmaceuticals has a market cap or net worth of $2.01 billion as of May 9, 2025. Its market cap has increased by 62.80% in one year.

Market Cap

2.01B

Enterprise Value

1.81B

1-Year Change

62.80%

Ranking

#1875

Market Cap Chart

Since December 1, 1998, Ligand Pharmaceuticals's market cap has increased from $430.80M to $2.01B, an increase of 367.61%. That is a compound annual growth rate of 6.00%.

Market Cap History

Date	Market Cap	% Change
May 8, 2025	1.97B	-2.50%
Dec 31, 2024	2.02B	62.58%
Dec 29, 2023	1.25B	10.35%
Dec 30, 2022	1.13B	-56.28%
Dec 31, 2021	2.58B	61.30%
Dec 31, 2020	1.60B	-12.63%
Dec 31, 2019	1.83B	-36.49%
Dec 31, 2018	2.88B	-0.20%
Dec 29, 2017	2.89B	36.08%
Dec 30, 2016	2.12B	-1.70%
Dec 31, 2015	2.16B	102.78%
Dec 31, 2014	1.07B	-0.76%
Dec 31, 2013	1.07B	159.26%
Dec 31, 2012	414.10M	77.34%
Dec 30, 2011	233.50M	33.50%
Dec 31, 2010	174.90M	-28.67%
Dec 31, 2009	245.20M	-5.73%
Dec 31, 2008	260.10M	-43.57%
Dec 31, 2007	460.90M	-46.88%
Dec 29, 2006	867.60M	4.96%
Dec 30, 2005	826.60M	-3.95%
Dec 31, 2004	860.60M	-19.85%
Dec 31, 2003	1.07B	179.68%
Dec 31, 2002	383.90M	-64.11%
Dec 31, 2001	1.07B	34.96%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	670.25B
Johnson & Johnson	372.27B
UnitedHealth Group	344.53B
AbbVie	331.03B
Novo Nordisk	297.79B
Abbott Laboratories	232.98B
Novartis AG	215.89B
AstraZeneca	211.14B

Market Cap Rankings